fda semaglutide compounding warning november 2025 letters National Hispanic Medical Association FDA Warning Letter Breakdown: Sterility

According to the recently completed ELIXA and LEADER trials, an increase in HR, regardless of its magnitude, does not appear to increase the cardiovascular risk of individuals with T2DM and with (or at high risk of) cardiovascular disease

But it erodes the buffer at a time when the underlying business is facing a far bigger structural challenge

Over 60% of them took liraglutide, semaglutide, or tirzepatide

You may be eating the same, moving your body, doing everything "right," and still watching your body change

Dexcom G7 is easy to use and allows you to see how food, medication, and activity affect your glucose levels in real time